Please use this identifier to cite or link to this item:
Title: Evaluation of vancomycin MIC creep in methicillin-resistant Staphylococcus aureus infections-a systematic review and meta-analysis
Author: Diaz, R
Afreixo, V
Ramalheira, E
Rodrigues, C.
Gago, B
Keywords: Anti-Bacterial Agents
Microbial Sensitivity Tests
Staphylococcal Infections
Methicillin-Resistant Staphylococcus aureus
Issue Date: Feb-2018
Publisher: Elsevier
Abstract: Vancomycin is currently the primary option treatment for methicillin-resistant Staphylococcus aureus (MRSA). However, an increasing number of MRSA isolates with high MICs, within the susceptible range (vancomycin MIC creep), are being reported worldwide. Resorting to a meta-analysis approach, this study aims to assess the evidence of vancomycin MIC creep.
Peer review: yes
DOI: 10.1016/j.cmi.2017.06.017
ISSN: 1198-743X
Appears in Collections:CIDMA - Artigos
IBIMED - Artigos
DMat - Artigos
PSG - Artigos

Files in This Item:
File Description SizeFormat 
Diaz2018b.pdf1.08 MBAdobe PDFView/Open

FacebookTwitterDeliciousLinkedInDiggGoogle BookmarksMySpace
Formato BibTex MendeleyEndnote Degois 

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.